Limited coverage drugs – carvedilol

Last updated on January 22, 2024

Special Authority requests can now be submitted online. It's simple and quick!

This drug is eligible for automatic approval when patient meets criteria and the request is submitted by eForms.

Generic name	carvedilol
Strength	3.125 mg, 6.25 mg, 12.5 mg, 25 mg
Form	tablet

Special Authority criteria	Approval period
For treatment of stable symptomatic congestive heart failure PLUS Concurrent therapy with an Angiotensin Converting Enzyme Inhibitor (ACE-I)	Indefinite

Special Authority criteria

Approval period

For treatment of stable symptomatic congestive heart failure

PLUS

Concurrent therapy with an Angiotensin Converting Enzyme Inhibitor (ACE-I)

Indefinite

Practitioner exemptions

None

Special notes

None

Special Authority requests

Log in to eForms
HLTH 5328 - Special Authority Request (PDF, 656KB)

Did you find what you were looking for?

The B.C. Public Service acknowledges the territories of First Nations around B.C. and is grateful to carry out our work on these lands. We acknowledge the rights, interests, priorities, and concerns of all Indigenous Peoples - First Nations, Métis, and Inuit - respecting and acknowledging their distinct cultures, histories, rights, laws, and governments.

More topics

Limited coverage drugs – carvedilol

Practitioner exemptions

Special notes

Special Authority requests